Ibrahim Halil Sahin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers (NCT06365970) | Ibrahim Halil Sahin | 2025-01-31 |
Track Ibrahim Halil Sahin automatically
Every clearance here is in the API, with alerts when new ones post.